BlogWithIntegrity.com
Please subscribe to ML!
Breast Cancer | cancer causes | cancer diagnosis | cancer treatment | Future of Medicine | Oncology (cancer) | Pathology | Science | Under the Radar

Considering 10 Newly-Defined Molecular Subtypes of Breast Cancer in Nature, and a Dream

500px-Cluster-2

The 10 mol­e­cular BC cat­e­gories bear prog­nostic (sur­vival) infor­mation and, based on their dis­tinct muta­tions and gene expression pat­terns, potential targets for novel drugs.…I wonder if, in a few years, some breast cancers might be treated without surgery.

See more 10 Newly-​​​​Defined Mol­e­cular Types of Breast Cancer in Nature, and a Dream

clinical trials | health care costs | health care delivery | journalism | Medical News | Statistics

A JAMA Press Briefing on CER, Helicopters and Time for Questions

MASH-tv-show-15

What’s clear is that depending on how inves­ti­gators adjust or manip­ulate or clarify or frame or present data – you choose the verb – they might show dif­fering results. This doesn’t just pertain to data on trauma and helicopters…

See more A JAMA Press Briefing on CER, Heli­copters and Time for Questions

Books | Future of Medicine | Reviews | Science

Review: Dr. Eric Topol's Creative Destruction of Medicine

Facebook Like

Topol’s com­fortable writing about the inter­section of science and med­icine as few physi­cians are.…One theme that emerges through the book is the capacity for tech­nology – by “knowing” and pro­cessing so much real-​​time infor­mation about each person’s con­dition — to inform more effective, indi­vid­u­alized treatments.

See more Review: Dr. Eric Topol’s Cre­ative Destruction of Medicine

Breast Cancer | cancer screening | Communication | Diagnosis | journalism | Medical News | Oncology (cancer) | Women's Health

New Article on Mammography Spawns False Hope That Breast Cancer is Not a Dangerous Disease

Few forms of invasive breast cancer warrant no treatment unless the patient is so old that she is likely to die first of another con­dition, or the patient prefers to die of the disease.…“Mammograms Spot Cancers That May Not Be Dan­gerous,” said WebMD, yes­terday. This is feel-​​good news, and largely wishful.

See more New Article on Mam­mog­raphy Spawns False Hope That Breast Cancer is Not a Dan­gerous Disease

Life in NYC | Magazine | Nutrition | Public Health | Women's Health

Reading on Christine Quinn, Who Might Become NYC Mayor, and Public Health

NYC Council Speaker Christine Quinn marching in a Gay Pride event on Staten Island, June 2008 (Wikimedia Commons)

This week’s New Yorker pro­files Christine Quinn, Speaker of the NYC City Council. I don’t know Ms. Quinn per­sonally, so I was glad for the likely fact-​​​​checked bio of the woman who might be my next mayor.

NYC Council Speaker Christine Quinn marching in a Gay Pride event on Staten Island, June 2008 (Wiki­media Commons)

It turns out that Quinn lost her mother to breast cancer when she was 16 years old. This interests me at several levels. Surely, the life-​​​​long effects of such a loss vary among souls — from bit­terness to ambition to kindliness. I don’t know if the Speaker holds par­ticular sym­pa­thies for BC causes, or gives to cancer-​​​​related agencies. I wonder if she’s a little more con­cerned about envi­ron­mental toxins that might con­tribute to disease, or a touch more gen­erous than the next NYC res­ident  in her attitude, gen­erally, about people who are sick and need care. But this is con­jecture, nothing more.

She’s

See more Reading on Christine Quinn, Who Might Become NYC Mayor, and Public Health

cancer screening | journalism | Medical Education | Oncology (cancer) | Statistics

What Does it Mean if Primary Care Doctors Get the Answers Wrong About Screening Stats?

The new findings have no bearing on whether or not cancer screening is cost-​​effective or life-​​saving. What the study does suggest is that med school math require­ments should be upped and rig­orous, counter to the trend

See more What Does it Mean if Primary Care Doctors Get the Answers Wrong About Screening Stats?

Economics | health care delivery | Life as a Patient | Medical News | Public Health

Counterfeit Drugs: A New Concern for Patients

Counterfeit Avastin (images from FDA)

Coun­terfeit vials were sold and dis­tributed to more than a dozen offices and medical treatment facil­ities in the U.S. This event, which seems to have affected a small number of patients and prac­tices, should sound a big alarm.

See more Coun­terfeit Drugs, A New Concern for Patients

Medical News | pharmacology | pulmonary | Science

Notes on Kalydeco, the New Cystic Fibrosis Drug

CFTR chromosome gene nlm image

The number of people living with cystic fibrosis in the U.S. is 30,000, according to the Cystic Fibrosis Foun­dation, so the FDA’s approval applies to approx­i­mately 1,200 indi­viduals — the 4% — who carry the G551D mutation.

See more Notes on Kalydeco, the New Cystic Fibrosis Drug

Communication | Diagnosis | Health IT | Medical News | Psychiatry | Tuesday Term

Cyberchondria Rising - What is the Term's Meaning and History?

Yes­terday the AMA news informed me that cyber­chondria is on the rise. So it’s a good moment to con­sider the term’s meaning and history.

Cyber­chondria is an unfounded health concern that develops upon searching the Internet for infor­mation about symptoms or a disease. A cyber­chon­driac is someone who surfs the Web about a medical problem and worries about it unduly.

Through Wikipedia, I located what might be the first ref­erence to cyber­chondria in a medical journal: a 2003 article in the Journal of Neu­rology, Neu­ro­surgery, and Psy­chiatry. A section on the new diag­nosis starts like this: “Although not yet in the Oxford English Dic­tionary, the word ‘cyber­chondria’ has been coined to describe the excessive use of internet health sites to fuel health anxiety.” That aca­demic report links back to a 2001 story in the Inde­pendent, “Are you a Cyberchondriac?”

Two Microsoft researchers, Ryen White and Eric Horvitz, authored a “classic” paper: Cyber­chondria: Studies of the Esca­lation of Medical Concerns

See more Cyber­chondria Rising — What is the Term’s Meaning and History?

Academic Medicine | clinical trials | Infectious Disease

NEJM Reports on 2 New Drugs for Hepatitis C

Last week’s NEJM delivered an intriguing, imperfect article on a new approach to treating hepatitis C (HCV). The paper’s careful title, Pre­lim­inary Study of Two Antiviral Agents for Hepatitis C Genotype 1, seems right. The analysis, with 17 authors listed, traces the response of 21 people with hepatitis C (HCV) who got two new anti-​​​​viral agents, with or without older drugs, in a clinical trial spon­sored by Bristol-​​​​Meyers Squibb.

The 21 study par­tic­i­pants all had chronic infection by HCV genotype 1, a strain that’s common in North America and rel­a­tively resistant to standard treatment. All sub­jects were between 18 and 70 years old, with a mea­surable level of HCV RNA in the blood, no evi­dence of cir­rhosis, and no response to prior HCV treatment (according to cri­teria detailed in the paper). In the trial, 11 patients received a com­bi­nation regimen of daclatasvir (60 mg once daily, by mouth) and asunaprevir (600 mg, twice daily by mouth) alone; the other 10 patients took the exper­i­mental drugs

See more NEJM Reports on 2 New Drugs for Hepatitis C

Get Adobe Flash player